Pub Date : 2022-11-01Epub Date: 2021-12-21DOI: 10.1177/00048674211065365
Elizabeth M Westrupp, Christopher J Greenwood, Matthew Fuller-Tyszkiewicz, Craig A Olsson, Emma Sciberras, Antonina Mikocka-Walus, Glenn A Melvin, Subhadra Evans, Mark A Stokes, Amanda G Wood, Gery C Karantzas, Jacqui A Macdonald, John W Toumbourou, Samantha J Teague, Julian W Fernando, Tomer S Berkowitz, Mathew Ling, George J Youssef
Objective: To control a second-wave COVID-19 outbreak, the state of Victoria in Australia experienced one of the world's first long and strict lockdowns over July-October 2020, while the rest of Australia experienced 'COVID-normal' with minimal restrictions. We (1) investigate trajectories of parent/child mental health outcomes in Victoria vs non-Victoria and (2) identify baseline demographic, individual and COVID-19-related factors associated with mental health trajectories.
Methods: Online community sample of 2004 Australian parents with rapid repeated assessment over 14 time-points over April 2020 to May 2021. Measures assessed parent mental health (Depression, Anxiety and Stress Scales-21), child depression symptoms (13-item Short Mood and Feelings Questionnaire) and child anxiety symptoms (four items from Brief Spence Children's Anxiety Scale).
Results: Mental health trajectories shadowed COVID-19 infection rates. Victorians reported a peak in mental health symptoms at the time of the second-wave lockdown compared to other states. Key baseline predictors, including parent and child loneliness (standardized regression coefficient [β] = 0.09-0.46), parent/child diagnoses (β = 0.07-0.21), couple conflict (β = 0.07-0.18) and COVID-19 stressors, such as worry/concern about COVID-19, illness and loss of job (β = 0.12-0.15), predicted elevated trajectories. Effects of predictors on parent and child mental health trajectories are illustrated in an online interactive app for readers (https://lingtax.shinyapps.io/CPAS_trend/).
Conclusion: Our findings provide evidence of worse trajectories of parent and child mental health symptoms at a time coinciding with a second COVID-19 outbreak involving strict lockdown in Victoria, compared to non-locked states in Australia. We identified several baseline factors that may be useful in detecting high-risk families who are likely to require additional support early on in future lockdowns.
{"title":"Parent and child mental health trajectories April 2020 to May 2021: Strict lockdown versus no lockdown in Australia.","authors":"Elizabeth M Westrupp, Christopher J Greenwood, Matthew Fuller-Tyszkiewicz, Craig A Olsson, Emma Sciberras, Antonina Mikocka-Walus, Glenn A Melvin, Subhadra Evans, Mark A Stokes, Amanda G Wood, Gery C Karantzas, Jacqui A Macdonald, John W Toumbourou, Samantha J Teague, Julian W Fernando, Tomer S Berkowitz, Mathew Ling, George J Youssef","doi":"10.1177/00048674211065365","DOIUrl":"https://doi.org/10.1177/00048674211065365","url":null,"abstract":"<p><strong>Objective: </strong>To control a second-wave COVID-19 outbreak, the state of Victoria in Australia experienced one of the world's first long and strict lockdowns over July-October 2020, while the rest of Australia experienced 'COVID-normal' with minimal restrictions. We (1) investigate trajectories of parent/child mental health outcomes in Victoria vs non-Victoria and (2) identify baseline demographic, individual and COVID-19-related factors associated with mental health trajectories.</p><p><strong>Methods: </strong>Online community sample of 2004 Australian parents with rapid repeated assessment over 14 time-points over April 2020 to May 2021. Measures assessed parent mental health (Depression, Anxiety and Stress Scales-21), child depression symptoms (13-item Short Mood and Feelings Questionnaire) and child anxiety symptoms (four items from Brief Spence Children's Anxiety Scale).</p><p><strong>Results: </strong>Mental health trajectories shadowed COVID-19 infection rates. Victorians reported a peak in mental health symptoms at the time of the second-wave lockdown compared to other states. Key baseline predictors, including parent and child loneliness (standardized regression coefficient [β] = 0.09-0.46), parent/child diagnoses (β = 0.07-0.21), couple conflict (β = 0.07-0.18) and COVID-19 stressors, such as worry/concern about COVID-19, illness and loss of job (β = 0.12-0.15), predicted elevated trajectories. Effects of predictors on parent and child mental health trajectories are illustrated in an online interactive app for readers (https://lingtax.shinyapps.io/CPAS_trend/).</p><p><strong>Conclusion: </strong>Our findings provide evidence of worse trajectories of parent and child mental health symptoms at a time coinciding with a second COVID-19 outbreak involving strict lockdown in Victoria, compared to non-locked states in Australia. We identified several baseline factors that may be useful in detecting high-risk families who are likely to require additional support early on in future lockdowns.</p>","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":" ","pages":"1491-1502"},"PeriodicalIF":4.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39742752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01Epub Date: 2021-12-28DOI: 10.1177/00048674211067720
Julie Klau, Carla De Oliveira Bernardo, David Alejandro Gonzalez-Chica, Melissa Raven, Jon Jureidini
Objective: To examine trends in prescribing psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018.
Method: A retrospective cohort study examined prescriptions written by general practitioners using MedicineInsight, a large Australian primary care database, covering approximately 9% of all general practitioner practices. Numbers of patients receiving prescriptions for five main classes of psychotropics (antipsychotics, antidepressants, attention deficit hyperactivity disorder medications, anxiolytics, and hypnotics/sedatives [including benzodiazepines and Z-drugs, but excluding melatonin]) were examined annually by age-group (0-4, 5-9, 10-14, 15-18 years). Melatonin was analysed separately.
Results: The number of patients prescribed any psychotropic increased from 25.6 to 36.2 per 1000 individuals from 2011 to 2018 (average annual increase +4.5%, 95% confidence interval [4.1%, 4.9%]; overall +41.4%). Among the five main classes, the largest annual increase was for attention deficit hyperactivity disorder medications (+9.6%, 95% confidence interval [8.8%, 10.5%]; overall +95.8%), followed by antipsychotics (+6.2%, 95% confidence interval [5.0%, 7.3%]; overall +62.8%) and antidepressants (+4.5%, 95% confidence interval [4.0%, 5.0%]; overall +42.8%). Hypnotic/sedative prescribing decreased on average 6.5% per year (95% confidence interval [-8.0%, -5.0%]; overall -40.2%). Anxiolytic prescribing remained steady. Melatonin prescriptions showed the highest increase of all (+24.7%, 95% confidence interval [23.7%, 25.8%]; overall +606.7%). The largest annual increase in antipsychotic, antidepressant or attention deficit hyperactivity disorder medication prescribing occurred in 10- to 14-year-olds (+7.5%, +6.5% and +10.4%, respectively). The largest point prevalence occurred in 2018 among 15- to 18-year-olds, with 98.5 per 1000 prescribed antidepressants. Antidepressants were more frequently prescribed to females; antipsychotics, attention deficit hyperactivity disorder medications and melatonin more often to males. The most prescribed antipsychotics were risperidone (<15 years) and quetiapine (15- to 18-year-olds). Fluoxetine was the most prescribed antidepressant in those aged 5+ years and amitriptyline in 0- to 4-year-olds.
Conclusion: General practitioner prescribing of melatonin, antipsychotics, antidepressants and attention deficit hyperactivity disorder medications to under-19-year-olds increased markedly from 2011 to 2018. Although benzodiazepine and Z-drug prescriptions declined, this was offset by a substantial increase in melatonin prescribing.
{"title":"Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018.","authors":"Julie Klau, Carla De Oliveira Bernardo, David Alejandro Gonzalez-Chica, Melissa Raven, Jon Jureidini","doi":"10.1177/00048674211067720","DOIUrl":"https://doi.org/10.1177/00048674211067720","url":null,"abstract":"<p><strong>Objective: </strong>To examine trends in prescribing psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018.</p><p><strong>Method: </strong>A retrospective cohort study examined prescriptions written by general practitioners using MedicineInsight, a large Australian primary care database, covering approximately 9% of all general practitioner practices. Numbers of patients receiving prescriptions for five main classes of psychotropics (antipsychotics, antidepressants, attention deficit hyperactivity disorder medications, anxiolytics, and hypnotics/sedatives [including benzodiazepines and Z-drugs, but excluding melatonin]) were examined annually by age-group (0-4, 5-9, 10-14, 15-18 years). Melatonin was analysed separately.</p><p><strong>Results: </strong>The number of patients prescribed any psychotropic increased from 25.6 to 36.2 per 1000 individuals from 2011 to 2018 (average annual increase +4.5%, 95% confidence interval [4.1%, 4.9%]; overall +41.4%). Among the five main classes, the largest annual increase was for attention deficit hyperactivity disorder medications (+9.6%, 95% confidence interval [8.8%, 10.5%]; overall +95.8%), followed by antipsychotics (+6.2%, 95% confidence interval [5.0%, 7.3%]; overall +62.8%) and antidepressants (+4.5%, 95% confidence interval [4.0%, 5.0%]; overall +42.8%). Hypnotic/sedative prescribing decreased on average 6.5% per year (95% confidence interval [-8.0%, -5.0%]; overall -40.2%). Anxiolytic prescribing remained steady. Melatonin prescriptions showed the highest increase of all (+24.7%, 95% confidence interval [23.7%, 25.8%]; overall +606.7%). The largest annual increase in antipsychotic, antidepressant or attention deficit hyperactivity disorder medication prescribing occurred in 10- to 14-year-olds (+7.5%, +6.5% and +10.4%, respectively). The largest point prevalence occurred in 2018 among 15- to 18-year-olds, with 98.5 per 1000 prescribed antidepressants. Antidepressants were more frequently prescribed to females; antipsychotics, attention deficit hyperactivity disorder medications and melatonin more often to males. The most prescribed antipsychotics were risperidone (<15 years) and quetiapine (15- to 18-year-olds). Fluoxetine was the most prescribed antidepressant in those aged 5+ years and amitriptyline in 0- to 4-year-olds.</p><p><strong>Conclusion: </strong>General practitioner prescribing of melatonin, antipsychotics, antidepressants and attention deficit hyperactivity disorder medications to under-19-year-olds increased markedly from 2011 to 2018. Although benzodiazepine and Z-drug prescriptions declined, this was offset by a substantial increase in melatonin prescribing.</p>","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":" ","pages":"1477-1490"},"PeriodicalIF":4.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39646605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: This study investigated trends in hospital-treated self-harm and hospital presenting suicidal ideation in the period before and after COVID-19 public health responses by key socio-demographic groups among those presenting to hospitals in the Western Sydney (Australia) population catchment.
Methods: Emergency department presentations for the period January 2016 to June 2021 were used to specify a series of interrupted time-series models to compare the observed and expected event rates of (1) hospital-treated self-harm and (2) hospital presenting suicidal ideation in the period following the onset of COVID-19 public health measures in March 2020. Rate differences between observed and expected rates in the post-implementation period were also estimated in models stratified by sex, age group, country of birth and socio-economic status.
Results: There was no significant increase in hospital-treated self-harm in the period post-implementation of public health orders (March 2020) compared to the previous period, although there were lower than expected rates of emergency department presentations among non-Australian-born males, males aged 0-14 years and 25-44 years, and females aged 45-64 years. In contrast, there was a significant increase in hospital presenting suicidal ideation, particularly among women (rate difference per 100,000 = 3.91, 95% confidence interval = [1.35, 6.48]) and those aged 15-24 years (both males and females, rate differences ranging from 8.91 to 19.04), and among those residing in lower socio-economic status areas (both males and females, rate differences ranging from 0.90 to 2.33).
Conclusion: There was no increase in hospital-treated self-harm rates in the 15 months post-implementation of COVID-19 public health orders in Western Sydney; however, there was a significant increase in hospital presenting suicidal ideation. The limited change in suicidal behaviour may reflect the success of social and economic supports during this period, the benefits of which may have been different for young people, and those of lower socio-economic status.
{"title":"The impact of the COVID-19 pandemic on hospital-treated self-harm in Sydney (Australia).","authors":"Sandro Sperandei, Andrew Page, Piumee Bandara, Arianne Reis, Rowena Saheb, Pankaj Gaur, Sithum Munasinghe, Kathryn Worne, Carolyn Fozzard, Vlasios Brakoulias","doi":"10.1177/00048674211068393","DOIUrl":"https://doi.org/10.1177/00048674211068393","url":null,"abstract":"<p><strong>Objectives: </strong>This study investigated trends in hospital-treated self-harm and hospital presenting suicidal ideation in the period before and after COVID-19 public health responses by key socio-demographic groups among those presenting to hospitals in the Western Sydney (Australia) population catchment.</p><p><strong>Methods: </strong>Emergency department presentations for the period January 2016 to June 2021 were used to specify a series of interrupted time-series models to compare the observed and expected event rates of (1) hospital-treated self-harm and (2) hospital presenting suicidal ideation in the period following the onset of COVID-19 public health measures in March 2020. Rate differences between observed and expected rates in the post-implementation period were also estimated in models stratified by sex, age group, country of birth and socio-economic status.</p><p><strong>Results: </strong>There was no significant increase in hospital-treated self-harm in the period post-implementation of public health orders (March 2020) compared to the previous period, although there were lower than expected rates of emergency department presentations among non-Australian-born males, males aged 0-14 years and 25-44 years, and females aged 45-64 years. In contrast, there was a significant increase in hospital presenting suicidal ideation, particularly among women (rate difference per 100,000 = 3.91, 95% confidence interval = [1.35, 6.48]) and those aged 15-24 years (both males and females, rate differences ranging from 8.91 to 19.04), and among those residing in lower socio-economic status areas (both males and females, rate differences ranging from 0.90 to 2.33).</p><p><strong>Conclusion: </strong>There was no increase in hospital-treated self-harm rates in the 15 months post-implementation of COVID-19 public health orders in Western Sydney; however, there was a significant increase in hospital presenting suicidal ideation. The limited change in suicidal behaviour may reflect the success of social and economic supports during this period, the benefits of which may have been different for young people, and those of lower socio-economic status.</p>","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":" ","pages":"1515-1522"},"PeriodicalIF":4.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39795004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01Epub Date: 2022-07-10DOI: 10.1177/00048674221109008
Philip E Mosley, Dennis Velakoulis, Sarah Farrand, Rodney Marsh, Adith Mohan, David Castle, Perminder Sachdev
1 Clinical Brain Networks Group, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia 2 Neurosciences Queensland, St Andrew’s War Memorial Hospital, Spring Hill, QLD, Australia 3 Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia 4 Faculty of Medicine, University of Queensland, Herston, QLD, Australia 5 Biomedical Informatics Group, CSIRO, Herston, QLD, Australia 6 Neuropsychiatry Unit, Royal Melbourne Hospital, Parkville, VIC, Australia 7 Melbourne Neuropsychiatry Centre, University of Melbourne and NorthWestern Mental Health, Parkville, VIC, Australia 8 Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, NSW, Australia 9 Neuropsychiatric Institute, The Prince of Wales Hospital, Randwick, NSW, Australia 10 Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, ON, Canada 11 Department of Psychiatry, University of Toronto, Toronto, ON, Canada
{"title":"Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: Opportunities and challenges.","authors":"Philip E Mosley, Dennis Velakoulis, Sarah Farrand, Rodney Marsh, Adith Mohan, David Castle, Perminder Sachdev","doi":"10.1177/00048674221109008","DOIUrl":"https://doi.org/10.1177/00048674221109008","url":null,"abstract":"1 Clinical Brain Networks Group, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia 2 Neurosciences Queensland, St Andrew’s War Memorial Hospital, Spring Hill, QLD, Australia 3 Queensland Brain Institute, University of Queensland, St Lucia, QLD, Australia 4 Faculty of Medicine, University of Queensland, Herston, QLD, Australia 5 Biomedical Informatics Group, CSIRO, Herston, QLD, Australia 6 Neuropsychiatry Unit, Royal Melbourne Hospital, Parkville, VIC, Australia 7 Melbourne Neuropsychiatry Centre, University of Melbourne and NorthWestern Mental Health, Parkville, VIC, Australia 8 Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales, Sydney, NSW, Australia 9 Neuropsychiatric Institute, The Prince of Wales Hospital, Randwick, NSW, Australia 10 Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, ON, Canada 11 Department of Psychiatry, University of Toronto, Toronto, ON, Canada","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":" ","pages":"1523-1524"},"PeriodicalIF":4.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40492076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01Epub Date: 2022-01-12DOI: 10.1177/00048674211067165
Anne Pf Wand, Roisin Browne, Tiffany Jessop, Carmelle Peisah
Objective: Self-harm is closely associated with suicide in older adults and may provide opportunity to intervene to prevent suicide. This study aimed to systematically review recent evidence for three components of aftercare for older adults: (1) referral pathways, (2) assessment tools and safety planning approaches and (3) engagement and intervention strategies.
Methods: Databases PubMed, Medline, PsychINFO, Embase and CINAHL were searched from January 2010 to 10 July 2021 by two reviewers. Empirical studies reporting aftercare interventions for older adults (aged 60+) following self-harm (including with suicidal intent) were included. Full text of articles with abstracts meeting inclusion criteria were obtained and independently reviewed by three authors to determine final studies for review. Two reviewers extracted data and assessed level of evidence (Oxford) and quality ratings (Alberta Heritage Foundation for Medical Research Standard Quality Assessment Criteria for quantitative and Attree and Milton checklist for qualitative studies), working independently.
Results: Twenty studies were reviewed (15 quantitative; 5 qualitative). Levels of evidence were low (3, 4), and quality ratings of quantitative studies variable, although qualitative studies rated highly. Most studies of referral pathways were observational and demonstrated marked variation with no clear guidelines or imperatives for community psychiatric follow-up. Of four screening tools evaluated, three were suicide-specific and one screened for depression. An evidence-informed approach to safety planning was described using cases. Strategies for aftercare engagement and intervention included two multifaceted approaches, psychotherapy and qualitative insights from older people who self-harmed, carers and clinicians. The qualitative studies identified targets for improved aftercare engagement, focused on individual context, experiences and needs.
Conclusion: Dedicated older-adult aftercare interventions with a multifaceted, assertive follow-up approach accompanied by systemic change show promise but require further evaluation. Research is needed to explore the utility of needs assessment compared to screening and evaluate efficacy of safety planning and psychotherapeutic approaches.
{"title":"A systematic review of evidence-based aftercare for older adults following self-harm.","authors":"Anne Pf Wand, Roisin Browne, Tiffany Jessop, Carmelle Peisah","doi":"10.1177/00048674211067165","DOIUrl":"10.1177/00048674211067165","url":null,"abstract":"<p><strong>Objective: </strong>Self-harm is closely associated with suicide in older adults and may provide opportunity to intervene to prevent suicide. This study aimed to systematically review recent evidence for three components of aftercare for older adults: (1) referral pathways, (2) assessment tools and safety planning approaches and (3) engagement and intervention strategies.</p><p><strong>Methods: </strong>Databases PubMed, Medline, PsychINFO, Embase and CINAHL were searched from January 2010 to 10 July 2021 by two reviewers. Empirical studies reporting aftercare interventions for older adults (aged 60+) following self-harm (including with suicidal intent) were included. Full text of articles with abstracts meeting inclusion criteria were obtained and independently reviewed by three authors to determine final studies for review. Two reviewers extracted data and assessed level of evidence (Oxford) and quality ratings (Alberta Heritage Foundation for Medical Research Standard Quality Assessment Criteria for quantitative and Attree and Milton checklist for qualitative studies), working independently.</p><p><strong>Results: </strong>Twenty studies were reviewed (15 quantitative; 5 qualitative). Levels of evidence were low (3, 4), and quality ratings of quantitative studies variable, although qualitative studies rated highly. Most studies of referral pathways were observational and demonstrated marked variation with no clear guidelines or imperatives for community psychiatric follow-up. Of four screening tools evaluated, three were suicide-specific and one screened for depression. An evidence-informed approach to safety planning was described using cases. Strategies for aftercare engagement and intervention included two multifaceted approaches, psychotherapy and qualitative insights from older people who self-harmed, carers and clinicians. The qualitative studies identified targets for improved aftercare engagement, focused on individual context, experiences and needs.</p><p><strong>Conclusion: </strong>Dedicated older-adult aftercare interventions with a multifaceted, assertive follow-up approach accompanied by systemic change show promise but require further evaluation. Research is needed to explore the utility of needs assessment compared to screening and evaluate efficacy of safety planning and psychotherapeutic approaches.</p>","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":" ","pages":"1398-1420"},"PeriodicalIF":0.0,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39814901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01DOI: 10.1177/00048674221132181
Gin S Malhi, Vlasios Brakoulias
The success of medical journals can be driven by various factors such as popularity, readership, submission rates, impact factor and download rates, but arguably the pursuit of academic excellence and the progression of science are the key end goals. There are also factors that can motivate editorial decisions that rely on threat and aversion such as fears of complaints, risk to reputation, legal threats and even risks to safety. This Editorial aims to provide an overview of the factors that threaten Editorial autonomy and to illustrate how politics can sometimes influence decisions rather than science.
{"title":"Impact, integrity and editorial independence.","authors":"Gin S Malhi, Vlasios Brakoulias","doi":"10.1177/00048674221132181","DOIUrl":"https://doi.org/10.1177/00048674221132181","url":null,"abstract":"The success of medical journals can be driven by various factors such as popularity, readership, submission rates, impact factor and download rates, but arguably the pursuit of academic excellence and the progression of science are the key end goals. There are also factors that can motivate editorial decisions that rely on threat and aversion such as fears of complaints, risk to reputation, legal threats and even risks to safety. This Editorial aims to provide an overview of the factors that threaten Editorial autonomy and to illustrate how politics can sometimes influence decisions rather than science.","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":" ","pages":"1373-1375"},"PeriodicalIF":4.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40673646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-01Epub Date: 2021-12-28DOI: 10.1177/00048674211065999
Mark Sinyor, Emilie Mallia, Claire de Oliveira, Ayal Schaffer, Thomas Niederkrotenthaler, Juveria Zaheer, Rachel Mitchell, David Rudoler, Paul Kurdyak
Objective: To determine whether the release of the first season of the Netflix series '13 Reasons Why' was associated with changes in emergency department presentations for self-harm.
Methods: Healthcare utilization databases were used to identify emergency department and outpatient presentations according to age and sex for residents of Ontario, Canada. Data from 2007 to 2018 were used in autoregressive integrated moving average models for time series forecasting with a pre-specified hypothesis that rates of emergency department presentations for self-harm would increase in the 3-month period following the release of 13 Reasons Why (1 April 2017 to 30 June 2017). Chi-square and t tests were used to identify demographic and health service use differences between those presenting to emergency department with self-harm during this epoch compared to a control period (1 April 2016 to 30 June 2016).
Results: There was a significant estimated excess of 75 self-harm-related emergency department visits (+6.4%) in the 3 months after 13 Reasons Why above what was predicted by the autoregressive integrated moving average model (standard error = 32.4; p = 0.02); adolescents aged 10-19 years had 60 excess visits (standard error = 30.7; p = 0.048), whereas adults demonstrated no significant change. Sex-stratified analyses demonstrated that these findings were largely driven by significant increases in females. There were no differences in demographic or health service use characteristics between those who presented to emergency department with self-harm in April to June 2017 vs April to June 2016.
Conclusions: This study demonstrated a significant increase in self-harm emergency department visits associated with the release of 13 Reasons Why. It adds to previously published mortality, survey and helpline data collectively demonstrating negative mental health outcomes associated with 13 Reasons Why.
{"title":"Emergency department visits for self-harm in adolescents after release of the Netflix series '13 Reasons Why'.","authors":"Mark Sinyor, Emilie Mallia, Claire de Oliveira, Ayal Schaffer, Thomas Niederkrotenthaler, Juveria Zaheer, Rachel Mitchell, David Rudoler, Paul Kurdyak","doi":"10.1177/00048674211065999","DOIUrl":"https://doi.org/10.1177/00048674211065999","url":null,"abstract":"<p><strong>Objective: </strong>To determine whether the release of the first season of the Netflix series '13 Reasons Why' was associated with changes in emergency department presentations for self-harm.</p><p><strong>Methods: </strong>Healthcare utilization databases were used to identify emergency department and outpatient presentations according to age and sex for residents of Ontario, Canada. Data from 2007 to 2018 were used in autoregressive integrated moving average models for time series forecasting with a pre-specified hypothesis that rates of emergency department presentations for self-harm would increase in the 3-month period following the release of 13 Reasons Why (1 April 2017 to 30 June 2017). Chi-square and <i>t</i> tests were used to identify demographic and health service use differences between those presenting to emergency department with self-harm during this epoch compared to a control period (1 April 2016 to 30 June 2016).</p><p><strong>Results: </strong>There was a significant estimated excess of 75 self-harm-related emergency department visits (+6.4%) in the 3 months after 13 Reasons Why above what was predicted by the autoregressive integrated moving average model (standard error = 32.4; <i>p</i> = 0.02); adolescents aged 10-19 years had 60 excess visits (standard error = 30.7; <i>p</i> = 0.048), whereas adults demonstrated no significant change. Sex-stratified analyses demonstrated that these findings were largely driven by significant increases in females. There were no differences in demographic or health service use characteristics between those who presented to emergency department with self-harm in April to June 2017 vs April to June 2016.</p><p><strong>Conclusions: </strong>This study demonstrated a significant increase in self-harm emergency department visits associated with the release of 13 Reasons Why. It adds to previously published mortality, survey and helpline data collectively demonstrating negative mental health outcomes associated with 13 Reasons Why.</p>","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":" ","pages":"1434-1442"},"PeriodicalIF":4.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/32/70/10.1177_00048674211065999.PMC9597162.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39646601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-01Epub Date: 2021-10-22DOI: 10.1177/00048674211051271
Francisco Tsz Tsun Lai, Vivien Kin Yi Chan, Tsz Wai Li, Xue Li, Stevan E Hobfoll, Tatia Mei-Chun Lee, Wai Kai Hou
Objective: There is a socioeconomic gradient to depression risks, with more pronounced inequality amid macroenvironmental potential traumatic events. Between mid-2019 and mid-2020, the Hong Kong population experienced drastic societal changes, including the escalating civil unrest and the COVID-19 pandemic. We examined the change of the socioeconomic gradient in depression and the potential intermediary role of daily routine disruptions.
Method: We conducted repeated territory-wide telephone surveys in July 2019 and July 2020 with 1112 and 2034 population-representative Cantonese-speaking Hong Kong citizens above 15 years old, respectively. Stratified by year, we examined the association between socioeconomic indicators (education attainment, household income, employment status and marital status) and probable depression (nine-item Patient Health Questionnaire [PHQ-9] ⩾ 10) using logistic regression. Differences in the socioeconomic gradient between 2019 and 2020 were tested. Finally, we performed a path analysis to test for the mediating role of daily routine disruptions.
Results: Logistic regression showed that higher education attainment in 2019 and being married in 2020 were protective against probable depression. Interaction analysis showed that the inverse association of higher education attainment with probable depression attenuated in 2020 but that of being married increased. Path analysis showed that the mediated effects through daily routine disruptions accounted for 95.9% of the socioeconomic gradient of probable depression in 2020, compared with 13.1% in 2019.
Conclusion: From July 2019 to July 2020, the mediating role of daily routine disruptions in the socioeconomic gradient of depression in Hong Kong increased. It is thus implied that infection control measures should consider the relevant potential mental health impacts accordingly.
{"title":"Disrupted daily routines mediate the socioeconomic gradient of depression amid public health crises: A repeated cross-sectional study.","authors":"Francisco Tsz Tsun Lai, Vivien Kin Yi Chan, Tsz Wai Li, Xue Li, Stevan E Hobfoll, Tatia Mei-Chun Lee, Wai Kai Hou","doi":"10.1177/00048674211051271","DOIUrl":"https://doi.org/10.1177/00048674211051271","url":null,"abstract":"<p><strong>Objective: </strong>There is a socioeconomic gradient to depression risks, with more pronounced inequality amid macroenvironmental potential traumatic events. Between mid-2019 and mid-2020, the Hong Kong population experienced drastic societal changes, including the escalating civil unrest and the COVID-19 pandemic. We examined the change of the socioeconomic gradient in depression and the potential intermediary role of daily routine disruptions.</p><p><strong>Method: </strong>We conducted repeated territory-wide telephone surveys in July 2019 and July 2020 with 1112 and 2034 population-representative Cantonese-speaking Hong Kong citizens above 15 years old, respectively. Stratified by year, we examined the association between socioeconomic indicators (education attainment, household income, employment status and marital status) and probable depression (nine-item Patient Health Questionnaire [PHQ-9] ⩾ 10) using logistic regression. Differences in the socioeconomic gradient between 2019 and 2020 were tested. Finally, we performed a path analysis to test for the mediating role of daily routine disruptions.</p><p><strong>Results: </strong>Logistic regression showed that higher education attainment in 2019 and being married in 2020 were protective against probable depression. Interaction analysis showed that the inverse association of higher education attainment with probable depression attenuated in 2020 but that of being married increased. Path analysis showed that the mediated effects through daily routine disruptions accounted for 95.9% of the socioeconomic gradient of probable depression in 2020, compared with 13.1% in 2019.</p><p><strong>Conclusion: </strong>From July 2019 to July 2020, the mediating role of daily routine disruptions in the socioeconomic gradient of depression in Hong Kong increased. It is thus implied that infection control measures should consider the relevant potential mental health impacts accordingly.</p>","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":" ","pages":"1320-1331"},"PeriodicalIF":4.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39541241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-01Epub Date: 2021-11-17DOI: 10.1177/00048674211058684
Dhamidhu Eratne, Shorena Janelidze, Charles B Malpas, Samantha Loi, Mark Walterfang, Antonia Merritt, Ibrahima Diouf, Kaj Blennow, Henrik Zetterberg, Brandon Cilia, Cassandra Wannan, Chad Bousman, Ian Everall, Andrew Zalesky, Mahesh Jayaram, Naveen Thomas, Samuel F Berkovic, Oskar Hansson, Dennis Velakoulis, Christos Pantelis, Alexander Santillo
Objective: Schizophrenia, a complex psychiatric disorder, is often associated with cognitive, neurological and neuroimaging abnormalities. The processes underlying these abnormalities, and whether a subset of people with schizophrenia have a neuroprogressive or neurodegenerative component to schizophrenia, remain largely unknown. Examining fluid biomarkers of diverse types of neuronal damage could increase our understanding of these processes, as well as potentially provide clinically useful biomarkers, for example with assisting with differentiation from progressive neurodegenerative disorders such as Alzheimer and frontotemporal dementias.
Methods: This study measured plasma neurofilament light chain protein (NfL) using ultrasensitive Simoa technology, to investigate the degree of neuronal injury in a well-characterised cohort of people with treatment-resistant schizophrenia on clozapine (n = 82), compared to first-degree relatives (an at-risk group, n = 37), people with schizophrenia not treated with clozapine (n = 13), and age- and sex-matched controls (n = 59).
Results: We found no differences in NfL levels between treatment-resistant schizophrenia (mean NfL, M = 6.3 pg/mL, 95% confidence interval: [5.5, 7.2]), first-degree relatives (siblings, M = 6.7 pg/mL, 95% confidence interval: [5.2, 8.2]; parents, M after adjusting for age = 6.7 pg/mL, 95% confidence interval: [4.7, 8.8]), controls (M = 5.8 pg/mL, 95% confidence interval: [5.3, 6.3]) and not treated with clozapine (M = 4.9 pg/mL, 95% confidence interval: [4.0, 5.8]). Exploratory, hypothesis-generating analyses found weak correlations in treatment-resistant schizophrenia, between NfL and clozapine levels (Spearman's r = 0.258, 95% confidence interval: [0.034, 0.457]), dyslipidaemia (r = 0.280, 95% confidence interval: [0.064, 0.470]) and a negative correlation with weight (r = -0.305, 95% confidence interval: [-0.504, -0.076]).
Conclusion: Treatment-resistant schizophrenia does not appear to be associated with neuronal, particularly axonal degeneration. Further studies are warranted to investigate the utility of NfL to differentiate treatment-resistant schizophrenia from neurodegenerative disorders such as behavioural variant frontotemporal dementia, and to explore NfL in other stages of schizophrenia such as the prodome and first episode.
{"title":"Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives.","authors":"Dhamidhu Eratne, Shorena Janelidze, Charles B Malpas, Samantha Loi, Mark Walterfang, Antonia Merritt, Ibrahima Diouf, Kaj Blennow, Henrik Zetterberg, Brandon Cilia, Cassandra Wannan, Chad Bousman, Ian Everall, Andrew Zalesky, Mahesh Jayaram, Naveen Thomas, Samuel F Berkovic, Oskar Hansson, Dennis Velakoulis, Christos Pantelis, Alexander Santillo","doi":"10.1177/00048674211058684","DOIUrl":"https://doi.org/10.1177/00048674211058684","url":null,"abstract":"<p><strong>Objective: </strong>Schizophrenia, a complex psychiatric disorder, is often associated with cognitive, neurological and neuroimaging abnormalities. The processes underlying these abnormalities, and whether a subset of people with schizophrenia have a neuroprogressive or neurodegenerative component to schizophrenia, remain largely unknown. Examining fluid biomarkers of diverse types of neuronal damage could increase our understanding of these processes, as well as potentially provide clinically useful biomarkers, for example with assisting with differentiation from progressive neurodegenerative disorders such as Alzheimer and frontotemporal dementias.</p><p><strong>Methods: </strong>This study measured plasma neurofilament light chain protein (NfL) using ultrasensitive Simoa technology, to investigate the degree of neuronal injury in a well-characterised cohort of people with treatment-resistant schizophrenia on clozapine (<i>n</i> = 82), compared to first-degree relatives (an at-risk group, <i>n</i> = 37), people with schizophrenia not treated with clozapine (<i>n</i> = 13), and age- and sex-matched controls (<i>n</i> = 59).</p><p><strong>Results: </strong>We found no differences in NfL levels between treatment-resistant schizophrenia (mean NfL, M = 6.3 pg/mL, 95% confidence interval: [5.5, 7.2]), first-degree relatives (siblings, M = 6.7 pg/mL, 95% confidence interval: [5.2, 8.2]; parents, M after adjusting for age = 6.7 pg/mL, 95% confidence interval: [4.7, 8.8]), controls (M = 5.8 pg/mL, 95% confidence interval: [5.3, 6.3]) and not treated with clozapine (M = 4.9 pg/mL, 95% confidence interval: [4.0, 5.8]). Exploratory, hypothesis-generating analyses found weak correlations in treatment-resistant schizophrenia, between NfL and clozapine levels (Spearman's <i>r</i> = 0.258, 95% confidence interval: [0.034, 0.457]), dyslipidaemia (<i>r</i> = 0.280, 95% confidence interval: [0.064, 0.470]) and a negative correlation with weight (<i>r</i> = -0.305, 95% confidence interval: [-0.504, -0.076]).</p><p><strong>Conclusion: </strong>Treatment-resistant schizophrenia does not appear to be associated with neuronal, particularly axonal degeneration. Further studies are warranted to investigate the utility of NfL to differentiate treatment-resistant schizophrenia from neurodegenerative disorders such as behavioural variant frontotemporal dementia, and to explore NfL in other stages of schizophrenia such as the prodome and first episode.</p>","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":" ","pages":"1295-1305"},"PeriodicalIF":4.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39631464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-01Epub Date: 2021-11-17DOI: 10.1177/00048674211057480
Luis Martinez Agulleiro, Renato de Filippis, Stella Rosson, Bhagyashree Patil, Lara Prizgint, Nahal Talasazan, Herbert Y Meltzer, John M Kane, Robert D Gibbons, Daniel Guinart
Objective: Self-reports or patient-reported outcome measures are seldom used in psychosis due to concerns about the ability of patients to accurately report their symptomatology, particularly in cases of low awareness of illness. The aim of this study was to assess the effect of insight on the accuracy of self-reported psychotic symptoms using a computerized adaptive testing tool (CAT-Psychosis).
Methods: A secondary analysis of data drawn from the CAT-Psychosis development and validation study was performed. The Brief Psychiatric Rating Scale and the Scale of Unawareness of Mental Disorders were administered by clinicians. Patients completed the self-reported version of the CAT-Psychosis. Patients were median-split regarding their insight level to compare the correlation between the two psychosis severity measures. A subgroup sensitivity analysis was performed only on patients with schizophrenia spectrum disorders.
Results: A total of 159 patients with a psychotic disorder who completed both CAT-Psychosis and Scale of Unawareness of Mental Disorders were included. For the whole sample, CAT-Psychosis scores showed convergent validity with Brief Psychiatric Rating Scale ratings (r = 0.517, 95% confidence interval = [0.392, 0.622], p < 0.001). Insight was found to moderate this correlation (β = -0.511, p = 0.005), yet agreement between both measures remained statistically significant for both high (r = 0.621, 95% confidence interval = [0.476, 0.733], p < 0.001) and low insight patients (r = 0.408, 95% confidence interval = [0.187, 0.589], p < 0.001), while psychosis severity was comparable between these groups (for Brief Psychiatric Rating Scale: U = 3057, z = -0.129, p = 0.897; disorganization: U = 2986.5, z = -0.274, p = 0.784 and for CAT-Psychosis: U = 2800.5, z = -1.022, p = 0.307). Subgroup of patients with schizophrenia spectrum disorders showed very similar results.
Conclusions: Insight moderates the correlation between self-reported and clinician-rated severity of psychosis, yet CAT-Psychosis remains valid in patients with both high and low awareness of illness.
目的:自我报告或患者报告的结果测量很少用于精神病,因为担心患者准确报告其症状的能力,特别是在疾病意识较低的情况下。本研究的目的是利用计算机化的适应性测试工具(CAT-Psychosis)评估洞察力对自我报告精神病症状准确性的影响。方法:对cat -精神病发展和验证研究的数据进行二次分析。由临床医师使用精神病学简易评定量表和精神障碍意识缺失量表。患者完成了自我报告版本的CAT-Psychosis。对患者的洞察力水平进行中位数分割,以比较两种精神病严重程度测量之间的相关性。亚组敏感性分析仅对精神分裂症谱系障碍患者进行。结果:共纳入159例完成CAT-Psychosis和《精神障碍意识缺失量表》的精神障碍患者。在整个样本中,cat2 - psychosis评分与《简短精神病学评定量表》评分呈收敛效度(r = 0.517, 95%可信区间= [0.476,0.733],p = 0.408, 95%可信区间= [0.187,0.589],p U = 3057, z = -0.129, p = 0.897),但两者之间的一致性仍然具有统计学意义(r = 0.621, 95%可信区间= [0.492,0.622],p p = 0.005);混乱:U = 2986.5, z = -0.274, p = 0.784和CAT-Psychosis: U = 2800.5, z = -1.022, p = 0.307)。精神分裂症谱系障碍患者亚组显示了非常相似的结果。结论:洞察力调节了自我报告和临床评定的精神病严重程度之间的相关性,但CAT-Psychosis在疾病意识高和低的患者中仍然有效。
{"title":"Awareness of illness moderates self-assessment of psychotic symptoms.","authors":"Luis Martinez Agulleiro, Renato de Filippis, Stella Rosson, Bhagyashree Patil, Lara Prizgint, Nahal Talasazan, Herbert Y Meltzer, John M Kane, Robert D Gibbons, Daniel Guinart","doi":"10.1177/00048674211057480","DOIUrl":"https://doi.org/10.1177/00048674211057480","url":null,"abstract":"<p><strong>Objective: </strong>Self-reports or patient-reported outcome measures are seldom used in psychosis due to concerns about the ability of patients to accurately report their symptomatology, particularly in cases of low awareness of illness. The aim of this study was to assess the effect of insight on the accuracy of self-reported psychotic symptoms using a computerized adaptive testing tool (CAT-Psychosis).</p><p><strong>Methods: </strong>A secondary analysis of data drawn from the CAT-Psychosis development and validation study was performed. The Brief Psychiatric Rating Scale and the Scale of Unawareness of Mental Disorders were administered by clinicians. Patients completed the self-reported version of the CAT-Psychosis. Patients were median-split regarding their insight level to compare the correlation between the two psychosis severity measures. A subgroup sensitivity analysis was performed only on patients with schizophrenia spectrum disorders.</p><p><strong>Results: </strong>A total of 159 patients with a psychotic disorder who completed both CAT-Psychosis and Scale of Unawareness of Mental Disorders were included. For the whole sample, CAT-Psychosis scores showed convergent validity with Brief Psychiatric Rating Scale ratings (<i>r</i> = 0.517, 95% confidence interval = [0.392, 0.622], <i>p</i> < 0.001). Insight was found to moderate this correlation (β = -0.511, <i>p</i> = 0.005), yet agreement between both measures remained statistically significant for both high (<i>r</i> = 0.621, 95% confidence interval = [0.476, 0.733], <i>p</i> < 0.001) and low insight patients (<i>r</i> = 0.408, 95% confidence interval = [0.187, 0.589], <i>p</i> < 0.001), while psychosis severity was comparable between these groups (for Brief Psychiatric Rating Scale: <i>U</i> = 3057, <i>z</i> = -0.129, <i>p</i> = 0.897; disorganization: <i>U</i> = 2986.5, <i>z</i> = -0.274, <i>p</i> = 0.784 and for CAT-Psychosis: <i>U</i> = 2800.5, <i>z</i> = -1.022, <i>p</i> = 0.307). Subgroup of patients with schizophrenia spectrum disorders showed very similar results.</p><p><strong>Conclusions: </strong>Insight moderates the correlation between self-reported and clinician-rated severity of psychosis, yet CAT-Psychosis remains valid in patients with both high and low awareness of illness.</p>","PeriodicalId":117457,"journal":{"name":"The Australian and New Zealand journal of psychiatry","volume":" ","pages":"1287-1294"},"PeriodicalIF":4.6,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39717731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}